Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q3 FY2022 Earnings Presentation
54 slides from Aster Dm Healthcare's earnings presentation, Feb 8, 2022
Slide 1: Cover letter to stock exchanges
February 08, 2022 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation for the quarter ended 31st December 2021
INVESTOR PRESENTATION For the quarter ended 31st December 2021
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Vision
VISION A Caring Mission with a Global Vision to Serve the World with Accessible and Affordable Quality Healthcare.
Slide 5: Aster DM Healthcare – Evolution
Aster DM Healthcare – Evolution New geographies, segments Brand “Aster” was formed, private Robust Growth across all Growth and Diversification into Building the foundations and service offerings equity investment, further expansion segments and geographies; aligned businesses across Rapid Expansion
Slide 6: Business Overview (9M)
Business Overview (9M) One of the 27 GCC : 13 Largest Private Healthcare 5,080 GCC : 1,160 Hospitals India : 14 service providers operating Capacity Beds India : 3,920 in Asia (GCC & India) Presence in 7 Countries 118 GCC : 109 (UAE, Saudi Arabia, Qatar, Oman, 13.6 Mn GCC. : 12.0 Mn Clinics India :
Slide 7: Geographical Footprint
6 Geographical Footprint United Arab Emirates Kingdom of Saudi Arabia Kerala Andhra Pradesh Karnataka H(8) C(95) P(210) H(1) H(5) P(13) L(24) H(4) C(4) H(3) C(5) P(69) L(42) Oman Qatar Bahrain Jordan Maharashtra Telangana H(3) C(6) P(6) H(1) C(6) P(5) C(2) P(2) P(10) H(1) H(1) P(8) GCC INDIA 13 109
Slide 8: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview Note: 1. Revenue and EBITDA shown above excludes other income 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated corpo
Slide 9: GCC Hospitals
GCC Hospitals 8 UAE Oman Aster Hospital Mankhool Aster Hospital Qusais Cedars Hospital Dubai Dubai Dubai Al Raffah Hospital Al Raffah Hospital Ibri Hospital CB:136 OB:118 CB:158 OB:126 CB:20 OB:14 Muscat Sohar Ibri 2015, Leased 2018, Leased 2019, Leased CB:72 OB:52 CB:80 OB:62 CB:31 OB:25 2009, Leas
Slide 10: India Hospitals
India Hospitals 9 Andhra & Telangana Cluster Kerala Cluster Karnataka & Maharashtra Cluster Dr Ramesh Main Aster Medcity Centre Kochi, Kerala Vijaywada, AP Aster CMI Aster RV Hospital CB: 709 OB: 532 CB:159 OB:135 Bengaluru, Bengaluru, 2014, Owned 2016, Leased Karnataka Karnataka CB:495 OB:326 CB:23
Slide 11: Hospitals: Pipeline Projects
Hospitals: Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Owned / Hospitals - India Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Note: 1. Agreement has been signed with Cayman government to set
Slide 12: The Aster DM Healthcare Edge
• Holistic healthcare solutions for people, The Aster DM including primary, secondary, tertiary and quaternary care Healthcare Edge • 27 Hospitals equipped with state-of-the-art equipment Robust & • Extensive network of 118 clinics enabling Expansive patient-feeder structure • Revenue contribution b
Slide 13: Robust Growth Over the Last 5 Years
Robust Growth Over the Last 5 Years Operational Beds (Census) Outpatient Count (in mn) Inpatient Count (in ‘000) ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 9M Hospitals 18 19 24 25 27 27 Clinics 96 101 114 117 115 118 Pharmacies - GCC 202 207 219 238
Slide 14: An Integrated Healthcare Provider
AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider
Slide 15: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY21 Operational Information 2,200+ 2,20,000+ Cardiovascular IP Discharges Surgeries ~4.7 mn 16,100+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 1,200+ 1,200+ Joint ~ 7.5 mn Spine Replacements Pharmacy Surgeries Visits 10,000+ 480+ Urology
Slide 16: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Patient Life Cycle Management • Aster, over 34 years, Hospitals Clinics Pharmacies has created a Healthcare Ecosystem across two geographical regions • Indian operations act as a source of talent (Doctors, Nurses, and • In GCC region, Aster’s other employees) Primary C
Slide 17: Digital Health
Digital Health Virtual Care- Omni-channel app for Patient interface Allows patients to register and book appointments online with the ability to pay in-app, thus saving time and effort Tele-consult with doctors Seamless integration with reports, allows patients to view all their patient data in the
Slide 18: Aster Labs
ORIGIN Aster Labs was established in 2019, with one true preposition of providing THE TRUE TEST. THE TRUE TEST is brand promise that every analysis will be the most accurate —and help doctors to diagnose better and ultimately help patients recover faster. Successfully served more than 11 Lakhs (till
Slide 19: Aster Pharmacy (India)
Initially to target 10 Kms radius around Aster Hospitals in all cities for expansion. (INDIA) Focusing on 2 store formats – 300 Sqft & 500 Sqft with 80:20 ratio Current Status Aster Pharmacy opened India’s 1st friendly neighborhood pharmacy in February 2021 and are rapidly expanding 90* stores
Slide 20: GCC Healthcare – Unique traits
GCC Healthcare – Unique traits Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) Due to lower % of older population, requirement of tertiary and quaterna
Slide 21: Aster - Awards & Service Excellence
20 Aster - Awards & Service Excellence Dr. Azad Moopen - Chairman and Managing Director Alisha Moopen - Deputy Managing Director • Recipient of the “Padma Shri” Award, the 4th highest civilian • Selected as one of the Top Next Generation award by the Government of India for being recognized Indian L
Slide 22: GCC Awards
Mother & Child AHPI Awards Aster Hospitals Dubai CAHO Awards Award Medcare Hospital Healthcare worker safety Medcare Mirdiff Dubai, Medcare award - Aster Sanad 2020 Specialty Center and G Dubai Quality Award DQA - Medcare Hospital Medcare Women and Orthopedics and Spine Hospital, Medcare C Children
Slide 23: Operational and Financial Overview
OPERATIONAL AND FINANCIAL OVERVIEW Operational and Financial Overview
Slide 24: Clinical Highlights - India and GCC
Clinical Highlights - India • • • • • Clinical Highlights - GCC • • • • •
Slide 25: Revenue and Profitability Snapshot – FY22 Q3
Revenue and Profitability Snapshot – FY22 Q3 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is ~ 18%, ~ 20% and ~ 60% respectively Notes: 1. Above financials are presented in INR Crore 2. Percentages mentioned insid
Slide 26: Revenue and Profitability Snapshot – FY22 9M
Revenue and Profitability Snapshot – FY22 9M Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is ~ 21%, ~ 38% and ~ 610% respectively Notes: 1. Above financials are presented in INR Crore 2. Percentages mentioned insi
Slide 27: Geography-wise Financial Snapshot – Quarterly
Geography – wise Financial – Snapshot – Quarterly GCC INDIA CONSOLIDATED FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 Revenue (₹) 1,768 Cr 2,032 Cr 459 Cr 618 Cr 2,228 Cr 2,650 Cr EBITDA (₹) 277 Cr 296 Cr 51 Cr 102 Cr 328 Cr 397 Cr PAT (Post-NCI) (₹) 104 Cr 121 Cr -11 Cr 27 Cr 92 Cr 148 Cr Notes:
Slide 28: Geography-wise Financial Snapshot – YTD
Geography – wise Financial – Snapshot – YTD GCC INDIA CONSOLIDATED FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 9M Revenue (₹) 5,044 Cr 5,749 Cr 1,173 Cr 1,776 Cr 6,218 Cr 7,525 Cr EBITDA (₹) 630 Cr 746 Cr 112 Cr 275 Cr 742 Cr 1,021 Cr PAT (Post-NCI) (₹) 107 Cr 251 Cr -64 Cr 49 Cr 42 Cr 300 Cr Notes
Slide 29: Geography-wise Business Snapshot – Quarterly
Geography – wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 Total Capacity Beds 1,165 1,160 3,708 3,920 4,873 5,080 Operational Beds (Census) 945 921 2,656 2,907 3,601 3,828 Operational Beds (Non-Census) 220 239 622 790 842 1,029 Available
Slide 30: Geography-wise Business Snapshot – YTD
Geography – wise Business – Snapshot - YTD GCC INDIA CONSOLIDATED FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 9M Total Capacity Beds 1,165 1,160 3,708 3,920 4,873 5,080 Operational Beds (Census) 945 921 2,656 2,907 3,601 3,828 Operational Beds (Non-Census) 220 239 622 790 842 1,029 Available Capaci
Slide 31: India Geography-wise Business Snapshot – Quarterly
Geography – wise Business – Snapshot - Quarterly KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 FY21 Q3 FY22 Q3 Total Capacity Beds 918 1,018 3,708 3,920 1,894 2,031 896 871 Operational Beds (Census) 614 722 2,656 2,907 1,395 1,583 647 602 Ope
Slide 32: India Geography-wise Business Snapshot – YTD
Geography – wise Business – Snapshot - YTD KARNATAKA & ANDHRA & KERALA TOTAL MAHARASHTRA TELANGANA FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 9M FY21 9M FY22 9M Total Capacity Beds 918 1,018 3,708 3,920 1,894 2,031 896 871 Operational Beds (Census) 614 722 2,656 2,907 1,395 1,583 647 602 Operation
Slide 33: Segmental Performance FY22 Q3
India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY22 Q3 GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 109 233 H-14, C-9, L-9 NA 387 Operational B
Slide 34: Segmental Performance FY22 9M
Segmental Performance FY22 9M India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY22 9M GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 109 233 H-14,
Slide 35: Maturity Wise Hospital Performance – GCC FY22 9M
Maturity Wise Hospital Performance – GCC FY22 9M Revenue Operational Beds EBITDA Maturity Hospitals (INR in Crs.) (Census) EBITDA % ARPOBD Occupancy (INR in Crs.) 3 13% 18% ₹49 51% 0-3 Years ₹333 165 ₹ ~144,600 14.7% Over 3 10 87% 82% ₹368 ₹ ~197,700 51% 16.3% Years ₹2,255 756 13 ₹ 2,588 921 ₹ ~188,
Slide 36: Maturity Wise Hospital Performance – India FY22 9M
Maturity Wise Hospital Performance – India FY22 9M Key Performance indicators Revenue Operational Beds EBITDA Maturity Hospitals (INR in Crs.) (Census) EBITDA % ARPOBD Occupancy (INR in Crs.) 16% 15% ₹34 0-3 Years ₹272 440 ₹ ~32,800 13.4% Over 3 84% 85% ₹275 ₹1,428 2,467 ₹ ~32,400 19.8% Years 13 ₹1,
Slide 37: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY22 Q2 FY21 Q3 FY22 Q3 Y-o-Y Gw% Q-o-Q Gw% As at Mar 31, As at Dec 31, Consolidated (INR Cr) 2021 2021 Revenue from operations 2,504 2,228 2,650 19% 6% Gross Debt 2,309 2,223 Material consumption 728 649 746 Less: Cash, Bank Bal
Slide 38: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY21 9M FY22 9M Gw% Revenue from operations 6,218 7,525 21% Material consumption 1,878 2,188 Doctors cost 1,308 1,509 Employee cost (excl. doctors) 1,210 1,486 Laboratory outsourcing charges 136 200 Other expenses 944 1,122 EBITD
Slide 39: Consol Trends
Consol Trends * * * * * * * * * * * * * * * Post IndAS 116 FY21 numbers have an impact of COVID
Slide 40: India: Financial Trends
India: Financial Trends *Post IndAS Capacity Beds Revenue EBITDA EBITDA Margin ROCE * * * * * * * * * ** ** ** During FY 21, the Company has incurred net loss on fair valuation of put option liability amounting to INR 14.55 crore which is included under other expenses, which is excluded from above E
Slide 41: India Cluster-Wise Trends
India Cluster-Wise Trends All figures except FY 19 are Post IndAS 116 The EBITDAR for K&M cluster for FY 22 9M is 15.6%
Slide 42: Strategy & Leadership
STRATEGY & LEADERSHIP Strategy & Leadership
Slide 43: Medical tourism network and cost optimization
Strengthening of our medical tourism network • To further strengthen integration of GCC & India operations to provide consistent quality experience to patients across geographies The pandemic allowed us to reflect and re- invent certain processes at all the locations. • To position our premium Enhan
Slide 44: India Strategy
India Strategy Aster DM Healthcare In line with hopes to leverage its focus on Focus on extensive experience derisking large format of working in a 100% business – hospitals in Tier 1 insurance market in target of 25% cities – Hospitals the GCC to derive of overall in Tier 1 cities better margins du
Slide 45: ESG: Committed to UN Sustainable Development Goals
ESG: Committed to UN Sustainable Development Goals
Slide 46: Aster Sustainability Report
Aster Sustainability Report 45 Aster’s FY2020-21 sustainability report – showcasing its contribution to multiple stakeholders and UNSDGs • Comprehensive as compared to the previous Sustainability reports • Prepared in accordance with the GRI standards: Core option • Mapped Aster’s ESG initiatives to
Slide 47: Aster's ESG Materiality Assessment
46 Economic Social Environment GRI 201: Economic GRI 413: Local GRI 302: Energy Performance communities GRI 303: Water Aster’s GRI 405: Diversity and equal opportunity GRI 306: Effluent and Waste ESG Materiality Assessment GRI 404: Training and education GRI 305: Emissions GRI 307: GRI 403: Occupati
Slide 48: Aster's commitment to UNSDG
Aster’s commitment The 17 Sustainable Development Goals are considered as the blueprint to achieve a sustainable future for all, it is important that we all work together to achieve them by to UNSGD 2030. At Aster, we have identified the goals relevant to our operations, and we are working towards t
Slide 49: Aster's alignment with SASB to focus on material issues
Aster’s alignment with SASB to focus on material issues Dimension Issue Efficient utilization of energy Optimizing water use Environment Climate Care Embracing circular economy Our people- Health and Safety, engagement, Diversity and Inclusion Volunteering program Response to COVID-19 Social Patient
Slide 50: Aster DM Healthcare - ESG update
Aster DM Healthcare - ESG update Environment Social Governance • Embedded Environmental parameters (energy • Code of Conduct policy is available and • The criteria for conducting the performance emission, water and biodiversity under CSR committed to providing employees with a safe evaluation of the
Slide 51: Aster – ESG Strategy
50 Aster – ESG Strategy Current ESG practices •External engagement for gap •ESG Policy and ESG Risk •ESG Pillars identified in assessment of Aster’s framework approved by the •Board level ESG commitment Sustainability Report 2020-21 Aster Board sustainability report against global frameworks Next st
Slide 52: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen T. J. Wilson Fara Siddiqi Alisha Moopen Sreenath Reddy Dr. Malathi Veneeth Purushotaman David Boucher Brandon Rowberry Amitabh Johri Dr. Shanila Laiju Dr. Sherbaz Bichu Bala NS Farhan Yasin Dr. Nitesh Shetty Devanand K T Sunil Kumar M R Anindya Chowdhury Ramakri
Slide 53: Aster Board of Directors
Aster Board of Directors Dr. Azad Moopen Alisha Moopen T. J. Wilson Anoop Moopen Shamsudheen Bin Daniel Robert Prof. Biju Varkkey Sridar Arvamudhan Mohideen Mammu Haji Mintz Iyengar Dr. Layla Mohamed Chenayappillil John James Mathew Wayne Earl Hassan Ali Al Marzooqi George Keathley
Slide 54: Thank You
Aster We'll Treat You Well Thank You www.asterdmhealthcare.com
Aster DM Healthcare — Q3 FY2022 Earnings Presentation on 6ix